Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Methotrexate, Cytarabine, and BEAM with PBSCT for PCNSL
NCT00003632Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 1998
- Primary completion
- Jul 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, cytarabine, carmustine, etoposide, melphalan in primary central nervous system lymphoma (PCNSL), sponsored by Memorial Sloan Kettering Cancer Center. Started Sep 1998; status: completed.
02
Drugs
methotrexatecytarabinecarmustineetoposidemelphalan
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00003632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003632.